A PHASE 1, OPEN-LABEL, DOSE-FINDING STUDY OF INCB050465 IN COMBINATION WITH INVESTIGATOR CHICE OF RITUXIMAB, BENDAMUSTINE AND RITUXIMAB, OR IBRUTINIB IN SUBJECTS WITH PREVIOUSLY TREATED B-CELL LYMPHOME (CITADEL-112)
2017-004088-11LINFOMA DE CÉLULAS TFundación Jiménez DíazInvestigador: CORDOBA MASCUÑANO RAUL
